West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Is the P/E ratio high or low?

The P/E ratio of 46.84 is in line with its 5-year average of 43.55, around the middle of its 5-year range (25.22–72.57).

As of Saturday, June 27, 2026. 20.66% above its 12-month average of 38.82.

PE Ratio (46.84) = Close Price ($350.85) / Diluted TTM EPS ($7.49)

WST PE Ratio

WST PE Ratio Chart

46.84
+36.24% 1Y
WST PE Ratio

WST Average PE Ratio Chart

WST PE Ratio

WST Current vs Average PE Ratio Chart

WST PE Ratio Metrics

PE RATIO

46.84

PE RATIO AVG TTM

38.82

PE RATIO AVG 3Y

43.21

PE RATIO AVG 5Y

43.53

PE RATIO AVG 10Y

47.63

PE RATIO AVG 15Y

41.87

PE RATIO AVG 20Y

36.33

CURRENT VS TTM AVG

+20.66%

CURRENT VS 3Y AVG

+8.39%

CURRENT VS 5Y AVG

+7.60%

CURRENT VS 10Y AVG

-1.66%

CURRENT VS 15Y AVG

+11.86%

CURRENT VS 20Y AVG

+28.95%

WST Competitors' PE Ratio

NAMEMARKET CAPPE RATIOTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B46.8438.8243.2143.53
Waters Corporation (WAT)vs ›$24.41B47.5732.5531.2430.52
Mettler-Toledo International Inc. (MTD)vs ›$25.54B29.5931.9132.7136.24
Quest Diagnostics Incorporated (DGX)vs ›$23.23B23.1921.8420.6717.13
BioNTech SE (BNTX)vs ›$23.07BN/A55.7322.6282.47
United Therapeutics Corporation (UTHR)vs ›$23.03B20.0617.3815.0016.04
Moderna, Inc. (MRNA)vs ›$26.69BN/A15.4632.5132.51
Incyte Corporation (INCY)vs ›$22.73B16.0734.02112.9879.77
DexCom, Inc. (DXCM)vs ›$27.07B29.9740.6469.62112.49
Labcorp Holdings Inc. (LH)vs ›$22.26B24.0526.9532.2123.52

P/E vs. its own history

At 46.8, P/E is richer than usual, sitting higher than 74% of its 20-year history.

20-year low

11.3

median

33.6

20-year high

79.6

cheaperricher

P/E Comparison

Trailing P/E

46.8

Forward P/E

36.6

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$350.85

÷

Forward EPS (Est.)

$9.58

=

Forward P/E

36.63

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PE Ratio FAQ

What is the P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The P/E ratio for WST stock is 46.84.
Is West Pharmaceutical Services, Inc.'s P/E ratio high or low?
The P/E ratio of 46.84 is in line with its 5-year average of 43.55, around the middle of its 5-year range (25.22–72.57).
What is the TTM average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The TTM average P/E ratio for WST stock is 38.82.
What is the 3Y average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The 3Y average P/E ratio for WST stock is 43.21.
What is the 5Y average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The 5Y average P/E ratio for WST stock is 43.53.
What is the 10Y average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The 10Y average P/E ratio for WST stock is 47.63.
What is the 15Y average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The 15Y average P/E ratio for WST stock is 41.87.
What is the 20Y average P/E ratio for West Pharmaceutical Services, Inc. (WST)?
The 20Y average P/E ratio for WST stock is 36.33.

WST PE Ratio History

DATEPE RATIO
2026-06-2646.84
2026-06-2546.27
2026-06-2445.45
2026-06-2344.91
2026-06-2244.02
2026-06-1843.79
2026-06-1743.20
2026-06-1644.00
2026-06-1544.25
2026-06-1243.90
2026-06-1144.10
2026-06-1044.18
2026-06-0944.68
2026-06-0842.69
2026-06-0541.99
2026-06-0442.37
2026-06-0342.23
2026-06-0241.68
2026-06-0142.23
2026-05-2943.10
2026-05-2842.96
2026-05-2741.75
2026-05-2642.21
2026-05-2242.25
2026-05-2142.21
2026-05-2040.79
2026-05-1940.58
2026-05-1840.64
2026-05-1540.44
2026-05-1440.08
2026-05-1340.37
2026-05-1241.66
2026-05-1143.03
2026-05-0843.51
2026-05-0742.99
2026-05-0641.73
2026-05-0541.38
2026-05-0440.08
2026-05-0140.14
2026-04-3039.73
2026-04-2939.43
2026-04-2839.00
2026-04-2740.35
2026-04-2440.88
2026-04-2341.35
2026-04-2240.35
2026-04-2140.40
2026-04-2040.88
2026-04-1740.25
2026-04-1639.68
2026-04-1539.19
2026-04-1439.40
2026-04-1338.23
2026-04-1037.73
2026-04-0938.02
2026-04-0839.11
2026-04-0738.14
2026-04-0637.77
2026-04-0237.47
2026-04-0137.17
2026-03-3136.86
2026-03-3036.05
2026-03-2735.79
2026-03-2636.49
2026-03-2536.33
2026-03-2436.07
2026-03-2335.50
2026-03-2034.86
2026-03-1935.34
2026-03-1835.15
2026-03-1735.21
2026-03-1635.34
2026-03-1334.63
2026-03-1233.98
2026-03-1135.04
2026-03-1034.39
2026-03-0936.48
2026-03-0636.16
2026-03-0535.93
2026-03-0436.59
2026-03-0336.97
2026-03-0236.95
2026-02-2737.40
2026-02-2636.62
2026-02-2536.45
2026-02-2436.09
2026-02-2335.91
2026-02-2035.46
2026-02-1935.86
2026-02-1836.51
2026-02-1735.76
2026-02-1337.05
2026-02-1236.04
2026-02-1136.41
2026-02-1036.03
2026-02-0936.82
2026-02-0636.83
2026-02-0534.26
2026-02-0435.07
2026-02-0334.16
2026-02-0235.13
2026-01-3034.19
2026-01-2934.42
2026-01-2834.89
2026-01-2735.58
2026-01-2635.71
2026-01-2335.01
2026-01-2236.65
2026-01-2137.75
2026-01-2037.06
2026-01-1638.43
2026-01-1541.33
2026-01-1440.68
2026-01-1340.21
2026-01-1240.37
2026-01-0940.76
2026-01-0840.71
2026-01-0741.19
2026-01-0641.52
2026-01-0541.28
2026-01-0240.89
2025-12-3140.70
2025-12-3040.96
2025-12-2940.77
2025-12-2640.58
2025-12-2440.93
2025-12-2341.05
2025-12-2240.66
2025-12-1940.32
2025-12-1839.74
2025-12-1739.81
2025-12-1639.41
2025-12-1540.22
2025-12-1239.58
2025-12-1140.32
2025-12-1039.49
2025-12-0939.36
2025-12-0839.80
2025-12-0541.45
2025-12-0441.68
2025-12-0342.06
2025-12-0240.39
2025-12-0140.55
2025-11-2841.01
2025-11-2641.00
2025-11-2541.54
2025-11-2440.53
2025-11-2140.10
2025-11-2038.13
2025-11-1938.15
2025-11-1838.48
2025-11-1738.82
2025-11-1438.66
2025-11-1339.45
2025-11-1240.51
2025-11-1141.04
2025-11-1040.75
2025-11-0740.09
2025-11-0640.73
2025-11-0541.94
2025-11-0442.45
2025-11-0341.39
2025-10-3141.73
2025-10-3041.20
2025-10-2942.14
2025-10-2841.94
2025-10-2742.49
2025-10-2444.00
2025-10-2345.45
2025-10-2241.47
2025-10-2141.82
2025-10-2041.15
2025-10-1740.51
2025-10-1640.00
2025-10-1539.36
2025-10-1439.10
2025-10-1339.29
2025-10-1039.19
2025-10-0939.46
2025-10-0840.11
2025-10-0739.82
2025-10-0640.13
2025-10-0340.80
2025-10-0240.89
2025-10-0140.63
2025-09-3039.27
2025-09-2938.97
2025-09-2639.15
2025-09-2538.10
2025-09-2438.91
2025-09-2337.54
2025-09-2237.76
2025-09-1938.15
2025-09-1838.17
2025-09-1738.42
2025-09-1638.68
2025-09-1538.55
2025-09-1237.95
2025-09-1139.48
2025-09-1038.21
2025-09-0937.73
2025-09-0837.90
2025-09-0537.53
2025-09-0437.06
2025-09-0337.27
2025-09-0236.49
2025-08-2936.97
2025-08-2836.74
2025-08-2736.82
2025-08-2636.60
2025-08-2537.01
2025-08-2237.10
2025-08-2136.32
2025-08-2036.88
2025-08-1936.97
2025-08-1836.39
2025-08-1536.86
2025-08-1436.86
2025-08-1336.86
2025-08-1235.91
2025-08-1135.98
2025-08-0836.07
2025-08-0736.01
2025-08-0635.52
2025-08-0535.76
2025-08-0435.69
2025-08-0135.82
2025-07-3135.82
2025-07-3037.31
2025-07-2937.87
2025-07-2838.59
2025-07-2539.45
2025-07-2441.78
2025-07-2335.68
2025-07-2234.36
2025-07-2132.98
2025-07-1833.11
2025-07-1734.79
2025-07-1635.22
2025-07-1534.70
2025-07-1435.24
2025-07-1135.66
2025-07-1035.99
2025-07-0935.51
2025-07-0834.61
2025-07-0734.77
2025-07-0334.89
2025-07-0234.73
2025-07-0134.92
2025-06-3034.35
2025-06-2734.36
2025-06-2634.38
2025-06-2534.70
2025-06-2434.96
2025-06-2334.02
2025-06-2033.88
2025-06-1834.22
2025-06-1734.23
2025-06-1635.21
2025-06-1334.84

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green